✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
The researcher decides to design a polymerase chain reaction (PCR) assay to screen HCM patients for the risk allele. To determine if a patient is homozygous for the risk allele, homozygous for the reference allele, or heterozygous (i.e. carries one copy of each allele), the assay must simultaneously amplify and measure the presence of both alleles (risk and reference).
Which approach would you recommend for the assay? (1 mark)
Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!